Imed is a property company in Wezembeek-Oppem. Private Limited, started on 26 July 1979, 1 establishment.

What is the address of Imed?

The registered office of Imed is located at Astridlaan 1, 1970 Wezembeek-Oppem.

Is Imed still active?

Yes. According to the CBE (29 October 2026) Imed is active, legal situation “Normale toestand”, started on 26 July 1979.

Is Imed registered on Peppol?

Yes, Imed is registered on the Peppol network with ID 0208:0419742853.

What is the enterprise number of Imed?

The enterprise number of Imed is BE0419742853.

When was Imed founded?

Imed was founded on 26 July 1979.

Who are the directors of Imed?

According to the 2025 annual accounts, the directors of Imed are: WILLEM-JAN LAUWERS, KIM LAUWERS, ERIK LAUWERS, CHRISTIAN LAUWERS.

Is Imed a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 July 1979; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did Imed make in 2025?

Imed recorded a loss after taxes of € 4,869 in financial year 2025.

What is the revenue of Imed?

As a small company, Imed is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 20,645.

Imed (Private Limited) - Wezembeek-Oppem - BE0419742853

Dossier Imed, printed on 29 October 2026 from databakkes.be/en/0419742853/imed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

Imed from Wezembeek-Oppem, company number BE0419742853, closed financial year 2025 with a result of € -4,869 after tax. For that financial year Imed recorded a gross margin of € 20,645 and equity of € 202,544. Compared with financial year 2024, the result moved from € -4,615 to € -4,869. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Healthy

€ 202,544

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -4,869

▼ 6 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,751

▲ € 6,714 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 3,668.

People and assets in 2025

Vehicles and equipment

€ 2,400

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 7,288

▲ 206% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 24,368 Gross margin 2022: € 24,368 First fiscal year in the series	€ 22,229 Gross margin 2023: € 22,229 ▼ 9% vs 2022 (€ 24,368) Unfavourable step	€ 23,193 Gross margin 2024: € 23,193 ▲ 4% vs 2023 (€ 22,229) Favourable step	€ 20,645 Gross margin 2025: € 20,645 ▼ 11% vs 2024 (€ 23,193) Unfavourable step	▼ 11%
Profit after taxes	€ -7,233 Profit after taxes 2022: € -7,233 First fiscal year in the series	€ -9,696 Profit after taxes 2023: € -9,696 ▼ € 2,463 vs 2022 (€ -7,233) Unfavourable step	€ -4,615 Profit after taxes 2024: € -4,615 ▲ € 5,081 vs 2023 (€ -9,696) Favourable step	€ -4,869 Profit after taxes 2025: € -4,869 ▼ € 254 vs 2024 (€ -4,615) Unfavourable step	▼ € 254
Equity	€ 221,723 Equity 2022: € 221,723 First fiscal year in the series	€ 212,027 Equity 2023: € 212,027 ▼ 4% vs 2022 (€ 221,723) Unfavourable step	€ 207,413 Equity 2024: € 207,413 ▼ 2% vs 2023 (€ 212,027) Unfavourable step	€ 202,544 Equity 2025: € 202,544 ▼ 2% vs 2024 (€ 207,413) Unfavourable step	▼ 2%
Total debts	€ 5,134 Total debts 2022: € 5,134 First fiscal year in the series	€ 8,131 Total debts 2023: € 8,131 ▲ 58% vs 2022 (€ 5,134) Unfavourable step	€ 5,470 Total debts 2024: € 5,470 ▼ 33% vs 2023 (€ 8,131) Favourable step	€ 15,730 Total debts 2025: € 15,730 ▲ 188% vs 2024 (€ 5,470) Unfavourable step	▲ 188%
Cash	€ 12,269 Cash 2022: € 12,269 First fiscal year in the series	€ 1,884 Cash 2023: € 1,884 ▼ 85% vs 2022 (€ 12,269) Unfavourable step	€ 2,037 Cash 2024: € 2,037 ▲ 8% vs 2023 (€ 1,884) Favourable step	€ 8,751 Cash 2025: € 8,751 ▲ € 6,714 vs 2024 (€ 2,037) Favourable step	▲ € 6,714
Land & buildings	€ 12,162 Land & buildings 2022: € 12,162 First fiscal year in the series	€ 4,440 Land & buildings 2023: € 4,440 ▼ 63% vs 2022 (€ 12,162) Unchanged	-	-
Retained profit	€ 22,847 Retained profit 2022: € 22,847 First fiscal year in the series	€ 13,151 Retained profit 2023: € 13,151 ▼ 42% vs 2022 (€ 22,847) Unfavourable step	€ 8,537 Retained profit 2024: € 8,537 ▼ 35% vs 2023 (€ 13,151) Unfavourable step	€ 3,668 Retained profit 2025: € 3,668 ▼ 57% vs 2024 (€ 8,537) Unfavourable step	▼ 57%
Balance sheet total	€ 227,460 Balance sheet total 2022: € 227,460 First fiscal year in the series	€ 220,159 Balance sheet total 2023: € 220,159 ▼ 3% vs 2022 (€ 227,460) Unchanged	€ 212,883 Balance sheet total 2024: € 212,883 ▼ 3% vs 2023 (€ 220,159) Unchanged	€ 218,274 Balance sheet total 2025: € 218,274 ▲ 3% vs 2024 (€ 212,883) Unchanged	▲ 3%

Key figures of Imed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Imed?

What happened at Imed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2026 New annual accounts for financial year 2025: loss of € 4,869. filed late Source: NBB ↗
2023 WILLEM-JAN LAUWERS became a director. NBB
2023 KIM LAUWERS became a director. NBB
2023 ERIK LAUWERS became a director. NBB
2023 CHRISTIAN LAUWERS became a director. NBB
Jul 26, 1979 New establishment in Wezembeek-Oppem. KBO
Jul 26, 1979 Start of the company according to the CBE. KBO

In short

From € 7,233 loss in 2022 to € 4,869 loss in 2025.

Original PDFs at the National Bank ↗

Management

WILLEM-JAN LAUWERS KIM LAUWERS ERIK LAUWERS CHRISTIAN LAUWERS

LOFMA

MGAaS

InsurTree

Imed

Behind Imed are WILLEM-JAN LAUWERS, KIM LAUWERS, ERIK LAUWERS and CHRISTIAN LAUWERS. KIM LAUWERS is also behind LOFMA, MGAaS, InsurTree, The Health Companion and BELGAMGA.

Directors

According to the 2025 annual accounts

WILLEM-JAN LAUWERS

Director

since 2023

KIM LAUWERS

Director

Also active at: LOFMA, MGAaS, InsurTree, The Health Companion, BELGAMGA, Cape One

since 2023

ERIK LAUWERS

Director

since 2023

CHRISTIAN LAUWERS

Managing director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Astridlaan 1

1970 Wezembeek-Oppem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0419.742.853
VAT number: BE 0419.742.853
Registered office: Astridlaan 1, 1970 Wezembeek-Oppem
Names & denominations: Imed
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 July 1979
Peppol: Active · Active since 29 Dec 2025
Activities · NACE: Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗

Imed

Warning lights

Financials

What happened to Imed?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions